Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Presystemic drug elimination.

P A Routledge, D G Shand

    Annual Review of Pharmacology and Toxicology
    |January 1, 1979
    PubMed
    Summary
    This summary is machine-generated.

    Presystemic elimination significantly reduces drug bioavailability. While the liver is well-studied, more research is needed on intestinal and lung metabolism to understand drug absorption.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    A change in the trend in dosulepin usage following the introduction of a prescribing indicator but not after two national safety warnings.

    Journal of clinical pharmacy and therapeutics·2016
    Same author

    A comparative study of methyldopa and labetalol in the treatment of hypertension.

    British journal of clinical pharmacology·2015
    Same author

    Mean steady-state plasma concentrations of labetalol in patients undergoing antihypertensive therapy.

    British journal of clinical pharmacology·2015
    Same author

    A multicentre open trial of labetalol in New Zealand.

    British journal of clinical pharmacology·2015
    Same author

    Impact of anti-cancer drugs and other determinants on serum protein binding of morphine 6-glucuronide.

    Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences·2012
    Same author

    Evidence of active transport involvement in morphine transport via MDCKII and MDCK-PGP cell lines.

    Research in pharmaceutical sciences·2011
    Same journal

    Navigating the Computational Landscape for Drug Repurposing.

    Annual review of pharmacology and toxicology·2026
    Same journal

    Microplastics and Atherosclerosis: Mechanisms.

    Annual review of pharmacology and toxicology·2026
    Same journal

    Treating Pregnant and Lactating Women: Insights from Clinical Pharmacology.

    Annual review of pharmacology and toxicology·2026
    Same journal

    <i>Caenorhabditis elegans</i> as a Model System for Environmental Mitotoxicants.

    Annual review of pharmacology and toxicology·2025
    Same journal

    Introduction to the Theme "New Approaches, Technology, and Techniques That Advance Pharmacology and Toxicology".

    Annual review of pharmacology and toxicology·2025
    Same journal

    A Mechanistic Framework for Repurposing FDA-Approved Drugs to Combat Antimicrobial Resistance: The Case of <i>Staphylococcus aureus</i>.

    Annual review of pharmacology and toxicology·2025
    See all related articles

    Area of Science:

    • Pharmacokinetics
    • Drug Metabolism
    • Bioavailability Studies

    Background:

    • Presystemic elimination is a major factor limiting oral drug bioavailability.
    • The liver, intestine, and lungs are key sites for presystemic metabolism.
    • Current data is insufficient for a complete understanding of intestinal and pulmonary contributions.

    Purpose of the Study:

    • To highlight the need for further investigation into intestinal and pulmonary presystemic metabolism.
    • To emphasize the importance of understanding these pathways for drug development.

    Main Methods:

    • Review of existing pharmacokinetic data.
    • Identification of knowledge gaps in presystemic elimination.
    • Discussion of kinetic analysis methods for assessing organ contributions.

    Related Experiment Videos

    Main Results:

    • The liver's role in presystemic elimination is well-documented.
    • Significant data gaps exist regarding intestinal and pulmonary metabolism.
    • Existing kinetic methods can evaluate the relative importance of different organs.

    Conclusions:

    • Further research on intestinal and pulmonary metabolism is crucial.
    • Understanding presystemic elimination is vital for improving oral drug bioavailability.
    • Kinetic analysis offers tools to assess the impact of different organs on drug absorption.